PLXS Q2 FY26: Revenue up 18.7% to $1.16B, margins expand, but FCF turns negative $34.6M

Filed May 7, 2026 · Period ending April 4, 2026 · ~1 min read

Key Changes

• high

  Net sales grew 18.7% to $1.16B in Q2, driven by new product ramps across all three geographic segments (AMER +34.5%, APAC +16.8%, EMEA +5.9%) and all three market sectors (Aerospace/Defense +23.0%, Industrial +20.6%, Healthcare/Life Sciences +15.1%).

  MD&A: Revenue Growth verify on EDGAR →
• high

  Free cash flow turned negative at $(34.6)M versus positive $43.6M prior year, a $78.2M deterioration driven by $170.7M inventory build to support ramping programs and $56.4M increase in receivables, partially offset by improved customer advance payments.

  MD&A: Cash Flow verify on EDGAR →
• high

  Operating margin expanded 30 basis points to 5.3% and gross margin improved 20 basis points to 10.2%, with net income up 27.4% to $49.8M and diluted EPS rising to $1.82 from $1.41 year-over-year.

  MD&A: Profitability verify on EDGAR →